Storyline
From the beginning to today
Researchers at the Cleveland Clinic published results of the first human trial of the experimental drug CTX310. This drug may reduce levels of 'bad' cholesterol in the blood by half and has successfully completed the first phase of trials.
1 of 1 events
the editorial blocs represented in the collected reporting
5 of 7 blocs are not represented in the collected reporting.